We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Metavesco Launches AI Investor Relations Agent for OTC Market
about 1 hour ago
Auddia Launches Discovr Radio at SXSW 2026 with Live Artist Demos
about 3 hours ago
GVT Unveils Major FAMCare Upgrades for Human Services Agencies
about 6 hours ago
AI Search Threatens Gaming Blogs, But Human Voices Still Win Readers
about 6 hours ago
HR News
GVT Unveils Major FAMCare Upgrades for Human Services Agencies
about 6 hours ago
HR.com Announces 2026 Leadership Development Award Winners
5 days ago
Global Hiring Accelerates Amid AI Reshaping and Engagement Strain in 2026
5 days ago
Fractional HR: Texas's Answer to Growth & Compliance Risks
12 days ago
HR.com Honors Top CHROs and Women Leaders in 2026 Awards
12 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
Williams Safety Launches SiteTracks: Real-Time Safety Platform for High-Risk Industries
13 minutes ago
SS Innovations Secures $18.6M to Fuel Global Robotic Surgery Expansion
43 minutes ago
Crypto News
Bitcoin Bancorp to Present at NIBA Conference, Showcasing ATM Network Expansion
about 2 hours ago
Crypto Market Slide in 2026: Grayscale Sees Long-Term Opportunity Amid Downturn
3 days ago
Utexo Raises $7.5M to Enable Bitcoin-Native USDT Settlement
3 days ago
Forward Industries Holds 6.97M SOL, Achieves 6.73% APY in Solana Treasury
4 days ago
Bitcoin Holds Steady Amid Middle East Tensions, Key for MicroStrategy
4 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
NeuroOne Hits Record Procedure Volume, Advances in $1B+ Pain & Brain Markets
43 minutes ago
Stress After Pregnancy Complications Raises Long-Term Heart Risk, Study Finds
about 4 hours ago
Technology News
Williams Safety Launches SiteTracks: Real-Time Safety Platform for High-Risk Industries
13 minutes ago
SS Innovations Secures $18.6M to Fuel Global Robotic Surgery Expansion
43 minutes ago
NeuroOne Hits Record Procedure Volume, Advances in $1B+ Pain & Brain Markets
43 minutes ago
Auddia Launches Discovr Radio at SXSW 2026 with Live Artist Demos
about 3 hours ago
AI Search Threatens Gaming Blogs, But Human Voices Still Win Readers
about 6 hours ago
Events & Conferences
Auddia Launches Discovr Radio at SXSW 2026 with Live Artist Demos
about 3 hours ago
Leading CME Conference Offers 26 Credits in Destin for Healthcare Pros
about 6 hours ago
NIN Ventures: Crowdfunding Fills VC Gap as Traditional Fundraising Slumps
about 6 hours ago
Feldman Orthodontics Sponsors 15th Annual Cheshire Road Race for Charity
about 14 hours ago
Hong Kong Jewellery Shows Draw 80,000 Buyers, Fuel Global Expansion
about 15 hours ago